Home Markets UBS bullish on AstraZeneca’s baxdrostat, cautious on AVANZAR

UBS bullish on AstraZeneca’s baxdrostat, cautious on AVANZAR

Jun 12, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/ubs-ullish-on-astrazenecas-baxdrostat-cautious-on-avanzar-93CH-4092432

You May Also Like

Google comes out on top as years-long Mexico antitrust case closed

Trump says Nippon-US Steel deal has resolvable national security risk

Football club investor Eagle files for US IPO, Bloomberg News reports

US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults

Boeing CEO cancels trip to Paris Airshow, GE postpones investor day after fatal crash

Norfolk Southern board elects Richard Anderson as chair